Cost Effectiveness of Health

HFMA’s Fifer, international panelists discuss how to improve investment in health

HFMA President and CEO Joe Fifer participated in an international summit that included a session on bolstering health through appropriate investment strategies.

Nick Hut September 9, 2021

Cost reporting in the time of COVID-19 could have an impact on hospital payment

The changes due to the COVID-19 pandemic that hospitals must report in their annual cost reports will be pervasive throughout the reported data. Given that CMS and some state agencies use cost reports i9nformation to establish future rates, it is critical that hospitals exercise heightened due diligence in preparing their cost reports throughout the public health emergency.

K. Michael Nichols, FHFMA, CPA September 2, 2021

Expense increases offset physician practice productivity and revenue gains

Physician groups across the country saw productivity and revenue improvements in the second quarter of 2021 compared with both the same period in 2020 and pre-pandemic levels seen in Q4 2019, according to Kaufman Hall’s latest Physician Flash Report. However, significant increases in expenses and continued high levels of physician investment compared with the pre-pandemic period remain areas of concern.

Matthew Bates September 1, 2021

Financial Sustainability Report: August 2021

The August 2021 issue of the Financial Sustainability Report, sponsored by Kaufman Hall, explores the impacts of COVID-19 on hospital cost reporting and financial statements, and why a hospital’s future payment levels may depend on its due diligence around these processes today.

HFMA September 1, 2021

HFMA’s Annual Conference virtual preview offers a glimpse of what’s coming in November

The three-hour virtual preview of the Annual Conference, including a look at the educational tracks, key speakers and other attractions, is available on-demand.

Nick Hut July 23, 2021

Financial Sustainability Report: July 2021

The July 2021 issue of the Financial Sustainability Report, sponsored by Kaufman Hall, includes an account of how one health system assessed the benefits and risk associated with moving its 340B covered-entity pharmacy enterprise to a Limited Liability Company. The issue also includes a commentary on CMS’s new Acute Hospital Care at Home program and a discussion of a new metric, equivalent net patient revenue (ENPR), which organizations can use to assess the relative value of proposed investments in alternative revenue sources.

HFMA July 23, 2021

Hospital care at home signifies an important innovation in acute care delivery

Although the CMS Acute Hospital Care at Home program is still early in its development in the U.S., early adopters show evidence of the program’s exciting promise, including positive impacts on health outcomes, an improved patient and provider experience, reduced cost of care and overall healthcare savings.

Shawn Stack July 23, 2021

Maintaining the equilibrium of the physician enterprise amid rapid change is a matter of balance

To ensure the proper functioning of the physician enterprise, hospitals and health systems must establish a balance among three dimensions: The clinicians’ productivity, the capacity to provide patients with access to care when they need it, and he volume of existing and potential patients in the market.

Matthew Bates July 21, 2021

ENPR: A metric for comparing alternative and top-line revenue strategies to enhance strategic growth

Health system CFOs today should be actively guiding their organizations toward strategic investments in alternative revenue sources that can strengthen the bottom line. An effective and relatable metric for evaluating such investments is equivalent net patient revenue (ENPR).

Jami Youmans, MHA July 21, 2021

Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study

University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.

Nathan Hagen, PharmD, MS July 21, 2021
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );